Related Experiment Videos
Molecular influences in thyroid and parathyroid surgery
1University Department of Surgery, Bristol Royal Infirmary, Bristol, UK.
Abstract:
Recent progress in molecular biology and genetics has made a major impact on the management of patients with multiple endocrine neoplasia syndromes MEN-1 and MEN-2. The understanding of the mechanisms involved in inherited thyroid and parathyroid tumours also offered valuable answers for other models of neoplasia. In addition, parathyroid surgery has witnessed rapid progress, from the cloning of the calcium receptor to the development of calcimimetics, a new class of drugs that could shift the management of hyperparathyroidism from surgical intervention to medical treatment. Laboratory techniques initially designed for research are more and more being used for clinical diagnosis. For example, the use of the polymerase chain reaction is currently being evaluated in the early diagnosis of metastatic thyroid carcinoma by identifying specific gene products in the local lymph nodes. This chapter attempts to convince the reader that molecular biology is no longer restricted to the laboratory but has an increasing impact on clinical decisions to which an endocrine surgeon is exposed.
Insights
Molecular biology advances are transforming endocrine surgery, impacting patient management for multiple endocrine neoplasia (MEN) syndromes and inherited tumors. New diagnostic tools and treatments like calcimimetics are shifting care from surgery to medicine.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
- Surgical Oncology
Background:
- Multiple Endocrine Neoplasia (MEN) syndromes (MEN-1 and MEN-2) management has been significantly influenced by molecular biology and genetics.
- Understanding inherited thyroid and parathyroid tumors provides insights into other neoplastic models.
- Advances in parathyroid surgery include calcium receptor cloning and calcimimetic drug development.
Purpose of the Study:
- To highlight the increasing impact of molecular biology on clinical decisions in endocrine surgery.
- To demonstrate the transition of laboratory techniques to clinical diagnostic applications.
- To emphasize the evolving landscape of hyperparathyroidism management.
Main Methods:
- Review of molecular biology and genetic advancements in endocrine neoplasia.
- Analysis of progress in parathyroid surgery and drug development (calcimimetics).
- Evaluation of emerging laboratory techniques for clinical diagnosis, such as polymerase chain reaction (PCR) for metastatic thyroid carcinoma detection.
Main Results:
- Molecular biology and genetics have substantially improved the management of MEN syndromes.
- Calcimimetics represent a potential shift from surgical to medical treatment for hyperparathyroidism.
- Research laboratory techniques, like PCR, are increasingly utilized for early clinical diagnosis of endocrine cancers.
Conclusions:
- Molecular biology is no longer confined to research but actively influences clinical decision-making for endocrine surgeons.
- The integration of molecular diagnostics and targeted therapies is revolutionizing endocrine patient care.
- Future endocrine surgery will likely involve closer collaboration with molecular biology and genetics.